BRPI0517413A - composições farmacêuticas com gosto mascarado - Google Patents

composições farmacêuticas com gosto mascarado

Info

Publication number
BRPI0517413A
BRPI0517413A BRPI0517413-9A BRPI0517413A BRPI0517413A BR PI0517413 A BRPI0517413 A BR PI0517413A BR PI0517413 A BRPI0517413 A BR PI0517413A BR PI0517413 A BRPI0517413 A BR PI0517413A
Authority
BR
Brazil
Prior art keywords
suspension
ready
pharmaceutical compositions
active substance
masked taste
Prior art date
Application number
BRPI0517413-9A
Other languages
English (en)
Inventor
Franz Xaver Schwarz
Irina Kosilek
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=33443791&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0517413(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of BRPI0517413A publication Critical patent/BRPI0517413A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

COMPOSIçõES FARMACêUTICAS COM GOSTO MASCARADO. A presente invenção refere-se a uma composição farmacêutica para administração oral adequada para a preparação de uma suspensão pronta para uso compreendendo partículas revestidas compreendendo uma substância ativa que tem um gosto desagradável e/ou amargo, tal como a claritromicina, e uma base de suspensão compreendendo uma substância osmoticamente ativa capaz de fornecer uma alta osmolalidade à mistura da base de suspensão com um meio aquoso para suspensão, na suspensão pronta para uso. A dita suspensão pronta para uso mantém a sua palatabilidade durante um prolongado período de tempo devido àquelas condições osmóticas definidas.
BRPI0517413-9A 2004-10-12 2005-10-10 composições farmacêuticas com gosto mascarado BRPI0517413A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0422645A GB2419094A (en) 2004-10-12 2004-10-12 Pharmaceutical composition of unpleasnt tasing active substances
PCT/EP2005/010890 WO2006040112A2 (en) 2004-10-12 2005-10-10 Taste-masking pharmaceutical compositions

Publications (1)

Publication Number Publication Date
BRPI0517413A true BRPI0517413A (pt) 2008-10-07

Family

ID=33443791

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0517413-9A BRPI0517413A (pt) 2004-10-12 2005-10-10 composições farmacêuticas com gosto mascarado

Country Status (14)

Country Link
US (1) US7767231B2 (pt)
EP (1) EP1802275B1 (pt)
JP (1) JP5134961B2 (pt)
CN (1) CN101083977B (pt)
AR (1) AR053977A1 (pt)
AU (1) AU2005293800B2 (pt)
BR (1) BRPI0517413A (pt)
CA (1) CA2581493C (pt)
ES (1) ES2514468T3 (pt)
GB (1) GB2419094A (pt)
RU (1) RU2399370C2 (pt)
SI (1) SI1802275T1 (pt)
WO (1) WO2006040112A2 (pt)
ZA (1) ZA200702418B (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5132090B2 (ja) * 2006-06-16 2013-01-30 東和薬品株式会社 塩酸エピナスチンドライシロップ剤
US9040089B2 (en) * 2008-07-22 2015-05-26 Lupin Limited Oral compositions of clindamycin
US9504274B2 (en) * 2009-01-27 2016-11-29 Frito-Lay North America, Inc. Methods of flavor encapsulation and matrix-assisted concentration of aqueous foods and products produced therefrom
CA2738573C (en) * 2009-04-03 2013-02-19 F. Hoffmann-La Roche Ag Compositions of propane-1 sulfonic acid {3-[5-(4-chloro-phenyl)-1h-pyrrolo[2,3-b]pyridine-3-carbonyl]-2,4-difluoro-phenyl}-amide and uses thereof
CN101879141B (zh) * 2009-05-05 2013-07-17 烟台绿叶动物保健品有限公司 一种掩味替米考星胃溶颗粒制剂
US20180104197A9 (en) 2014-05-01 2018-04-19 Sun Pharmaceutical Industries Limited Extended release liquid compositions of metformin
US20160317388A1 (en) * 2014-05-01 2016-11-03 Sun Pharmaceutical Industries Limited Dual-chamber pack for extended release suspension compositions
US10258583B2 (en) 2014-05-01 2019-04-16 Sun Pharmaceutical Industries Limited Extended release liquid compositions of guanfacine
CA2947528C (en) 2014-05-01 2023-09-05 Sun Pharmaceutical Industries Limited Extended release suspension compositions
US9962336B2 (en) * 2014-05-01 2018-05-08 Sun Pharmaceutical Industries Limited Extended release suspension compositions
BR112017001968A2 (pt) 2014-07-30 2017-11-21 Sun Pharmaceutical Ind Ltd embalagem de duas câmaras para uma composição farmacêutica líquida oral de múltiplas doses
US10369078B2 (en) 2016-05-02 2019-08-06 Sun Pharmaceutical Industries Limited Dual-chamber pack for pharmaceutical compositions
US10238803B2 (en) 2016-05-02 2019-03-26 Sun Pharmaceutical Industries Limited Drug delivery device for pharmaceutical compositions
WO2019136053A1 (en) * 2018-01-03 2019-07-11 Ferring B.V. Oral liquid pharmaceutical compositions of aminosalicylates
WO2020180690A1 (en) * 2019-03-01 2020-09-10 Avadel Legacy Pharmaceuticals, Llc Liquid pharmaceutical compositions with stable drug release profiles
CN115634203B (zh) * 2022-10-28 2024-06-25 南京海纳医药科技股份有限公司 一种含有依巴斯汀的干混悬剂及其制备方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3922379A (en) * 1973-12-17 1975-11-25 Abbott Lab Microencapsulation process
US4994260A (en) 1982-05-28 1991-02-19 Astra Lakemedel Aktiebolag Pharmaceutical mixture
NL193682C (nl) 1987-05-14 2000-07-04 Glaxo Group Ltd Beklede cefuroximaxetilsamenstelling.
US4808411A (en) 1987-06-05 1989-02-28 Abbott Laboratories Antibiotic-polymer compositions
US4853229A (en) * 1987-10-26 1989-08-01 Alza Corporation Method for adminstering tiny pills
IT1246383B (it) 1990-04-17 1994-11-18 Eurand Int Metodo per il mascheramento del sapore di farmaci
US5599556A (en) 1991-12-31 1997-02-04 Abbott Laboratories Prolamine coatings for taste masking
IL104093A (en) 1991-12-31 1999-06-20 Abbott Lab Prolamine is expected to mask the taste of drugs given orally
JPH05255073A (ja) * 1992-03-12 1993-10-05 Taisho Pharmaceut Co Ltd 経口製剤およびその製造方法
CA2143439A1 (en) * 1992-09-03 1994-03-17 Seang H. Yiv Taste-masking pharmaceutical compostiions and methods for making the same
WO1996003976A1 (en) * 1994-08-01 1996-02-15 Kv Pharmaceutical Corporation Tastemasked liquid pharmaceutical delivery system
AUPN969796A0 (en) * 1996-05-07 1996-05-30 F.H. Faulding & Co. Limited Taste masked liquid suspensions
EP0943341A1 (en) 1998-02-18 1999-09-22 Oscar Gold Procedure to prepare granulated compositions that contain erythromycin macrolides and procedure to prepare pharmaceutical compositions that contain said macrolides
WO2000076479A1 (en) 1999-06-11 2000-12-21 Ranbaxy Laboratories Limited Taste masked compositions
IN191239B (pt) 1999-06-11 2003-10-11 Ranbaxy Lab Ltd
CA2445606A1 (en) * 2001-05-11 2002-11-21 Pacific Pharmaceuticals Limited Taste masking pharmaceutical composition
FR2826274B1 (fr) * 2001-06-21 2003-09-26 Aventis Pharma Sa Formulation pharmaceutique au gout masque et son procede de preparation
KR100759635B1 (ko) * 2001-06-22 2007-09-17 화이자 프로덕츠 인코포레이티드 비정질 약물의 흡착체의 약학 조성물
DE10347994A1 (de) * 2003-10-15 2005-06-16 Pari GmbH Spezialisten für effektive Inhalation Wässrige Aerosol-Zubereitung

Also Published As

Publication number Publication date
CN101083977A (zh) 2007-12-05
CN101083977B (zh) 2013-03-06
AU2005293800B2 (en) 2009-03-26
SI1802275T1 (sl) 2014-11-28
JP5134961B2 (ja) 2013-01-30
AU2005293800A1 (en) 2006-04-20
CA2581493A1 (en) 2006-04-20
US20080008765A1 (en) 2008-01-10
GB2419094A (en) 2006-04-19
GB0422645D0 (en) 2004-11-10
WO2006040112A3 (en) 2007-04-26
RU2399370C2 (ru) 2010-09-20
AR053977A1 (es) 2007-05-30
ES2514468T3 (es) 2014-10-28
JP2008515946A (ja) 2008-05-15
WO2006040112A2 (en) 2006-04-20
EP1802275A2 (en) 2007-07-04
CA2581493C (en) 2013-02-19
EP1802275B1 (en) 2014-07-23
US7767231B2 (en) 2010-08-03
RU2007117499A (ru) 2008-11-20
ZA200702418B (en) 2009-04-29

Similar Documents

Publication Publication Date Title
BRPI0615292A8 (pt) composições e métodos para preparação de fármacos de má solubilidade em água com estabilidade aumentada
BR0207930A (pt) Composições farmacêuticas lìquidas com sabor mascarado
BRPI0411165A (pt) composição farmacêutica, forma de unidade de dosagem e métodos para preparar seu uso
BRPI0414000B8 (pt) composição farmacêutica sólida oral de liberação prolongada contendo tacrolimus na forma de uma dispersão sólida, forma de dosagem, e, uso da composição farmacêutica
NO20083104L (no) Fast preparat
AR053680A1 (es) Composicion
DE60142890D1 (de) 3-aminoazetidinderivate enthaltende pharmazeutische zusammensetzungen, diese derivate und deren herstellung
BRPI0508540A (pt) composto, composição farmacêutica, e, uso de um composto
CY1118179T1 (el) Φαρμακευτικη συνθεση
NO20076408L (no) Farmasoytisk preparat som inneholder gestagener og/eller ostrogener og 5-metyl-(6S)-tetrahydrofolat
AR053977A1 (es) Composiciones farmaceuticas con enmascaramiento de sabor
HN2002000319A (es) Benzamida, heteroarilamida y amidas inversas
BR0109672A (pt) Uso de zd6126 ou de um seu sal farmaceuticamente aceitável e um de: um agente antitumoral de plantina e um taxano, composição farmacêutica, produto de combinação, kit, e, método para a produção de um efeito de danificação vascular em um animal de sangue quente
BR9915111A (pt) Partìculas revestidas de ibuprofeno cristalinogranulado
CY1107819T1 (el) Φαρμακευτικη διαμορφωση της ολανζαπινης
DE60318447D1 (de) Pharmazeutische zusammensetzung enthaltend estetrolderivate und anwendung in der krebsbehandlung
BR0309057A (pt) Formulações lìquidas com baixa dosagem em entecavir e uso
PT1635852E (pt) ''utilização de composições para reconstituição de unhas para aplicação tópica em onicosquise''
HRP20050787A2 (en) Pharmaceutical composition comprising 5-methyl-2-2'-(chloro-6'-fluoroanilino) phenylacetic acid
BR0206979A (pt) Métodos e composições para reduzir o paladar de agentes farmaceuticamente ativos
ES2329801T3 (es) Preparacion farmaceutica para la cavidad oral.
Hughes et al. Preservative sensitization—Safety with and safety without
CO2025001080A2 (es) Una formulación líquida oral farmacéutica estable de un agente antiespasmódico
AR022462A1 (es) Uso de un agente que disminuye el colesterol
EA200601015A1 (ru) Пероральные композиции дезоксипеганина и их применение

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]